Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Eating less can improve stem cell function and increase lifespan.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

Mannosylerythritol lipids are good for skin and hair care products.

Defective mitochondrial DNA replication causes aging symptoms and increased oxidative damage in mice.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Researchers created a skin treatment that could effectively deliver medication into hair follicles.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hair loss may indicate higher heart risk and metabolic issues.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Obese and lean women with PCOS have different symptoms and need different treatments.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.